The Accounts · daily brief
18 May 2026
Coutts board pay rises, Churchill maintains polo sponsorship
The takeaways
- Two of today's filers managed profit surges on flat or modest revenue growth
- Headcount reductions at Oxford PharmaGenesis and Charles Wells improved operating margins
- A related-party polo sponsorship at Churchill is noted alongside a severe downside model
Coutts & Company [1]
Director pay rose
| Line | FY25 | FY24 | YoY |
|---|---|---|---|
| Profit & loss | |||
| Turnover | £990m | £882m | ▲ +12% |
| Gross profit | £351m | £243m | ▲ +44% |
| Admin expenses | £404m | £426m | ▼ −5% |
| Operating profit | £346m | £262m | ▲ +32% |
| Finance costs | £1.7bn | £1.8bn | ▼ −6% |
| Profit before tax | £346m | £262m | ▲ +32% |
| Net profit | £259m | £198m | ▲ +31% |
| People & pay | |||
| Avg. headcount | 2,347 | 2,339 | ▲ +0% |
| Staff cost | £235m | £213m | ▲ +10% |
| Director pay | £4.5m | £3.5m | ▲ +29% |
| Highest-paid director | £3.2m | £1.8m | ▲ +78% |
The private bank delivered a steady double-digit revenue expansion, but the real leverage showed up on the bottom line where operating profit surged. Headcount stayed entirely flat, which makes the 77% remuneration increase for the highest-paid director a notable data point. Ernst & Young signed off with a clean opinion on the unconsolidated accounts, though they flagged one key audit matter along the way.
Churchill Living (Developments) Plc [2]
Polo sponsorship
| Line | FY25 | FY24 | YoY |
|---|---|---|---|
| Profit & loss | |||
| Turnover | £169.8m | £149.4m | ▲ +14% |
| Gross profit | £53.4m | £51.3m | ▲ +4% |
| Admin expenses | £37.8m | — | |
| Operating profit | £15.8m | — | |
| Finance costs | £12.5m | £12.8m | ▼ −2% |
| Profit before tax | £3.3m | £3.9m | ▼ −14% |
| Net profit | £601k | £942k | ▼ −36% |
Revenue grew steadily for the retirement housebuilder, but net margins contracted enough to push the bottom line down by more than a third. The going-concern note is a detailed read, outlining a severe but plausible downside model that relies on shareholder support and a revolving credit facility. During the same period, the group accounts show over a million pounds was maintained for a related-party marketing sponsorship of a polo team.
Industrial Light & Magic (Uk) Ltd. [3]
Static top line
| Line | FY25 | FY24 | YoY |
|---|---|---|---|
| Profit & loss | |||
| Turnover | £94.3m | £91.7m | ▲ +3% |
| Gross profit | £41.1m | £42.4m | ▼ −3% |
| Admin expenses | £34.3m | £32.8m | ▲ +5% |
A broadly static year for the British arm of the visual effects house. Top-line revenue and gross profit barely moved from their prior marks, suggesting a steady pipeline of work without any dramatic expansion or contraction. The consolidated accounts read exactly as you would expect for a mature subsidiary maintaining its position.
Charles Wells Limited [4]
Directors' pay fell
| Line | FY25 | FY24 | YoY |
|---|---|---|---|
| Profit & loss | |||
| Turnover | £66.2m | £65.8m | ▲ +1% |
| Gross profit | £4.2m | £3.5m | ▲ +21% |
| Operating profit | £3.2m | £3.2m | ▼ −1% |
| Finance costs | £2.3m | £2.1m | ▲ +10% |
| Profit before tax | £1.8m | £1.2m | ▲ +50% |
| Net profit | £442k | £371k | ▲ +19% |
| People & pay | |||
| Avg. headcount | 827 | 874 | ▼ −5% |
| Staff cost | £41.9m | £40.8m | ▲ +3% |
| Director pay | £751k | £1.1m | ▼ −31% |
| Highest-paid director | £332k | £326k | ▲ +2% |
Top-line sales were entirely flat for the brewing and pub group, with margin improvements sourced internally. Average headcount fell by 5%, though interestingly the overall wage bill still crept up slightly. Total directors' remuneration dropped by nearly a third during the period, which helped to keep the overall administrative numbers in shape.
Oxford Pharmagenesis Holdings Limited [5]
Productivity gain
| Line | FY25 | FY24 | YoY |
|---|---|---|---|
| Profit & loss | |||
| Turnover | £57.1m | £55.4m | ▲ +3% |
| Gross profit | £27.9m | £25.2m | ▲ +11% |
| Admin expenses | £15.8m | £17.7m | ▼ −10% |
| Operating profit | £12.1m | £7.5m | ▲ +61% |
| Finance costs | £99,399 | £78,938 | ▲ +26% |
| Profit before tax | £12.3m | £7.9m | ▲ +55% |
| Net profit | £9.2m | £5.9m | ▲ +55% |
| People & pay | |||
| Avg. headcount | 453 | 496 | ▼ −9% |
| Staff cost | £31.7m | £36m | ▼ −12% |
| Director pay | £707k | £799k | ▼ −11% |
| Highest-paid director | £344k | £326k | ▲ +6% |
A clear demonstration of operating leverage from the medical communications group. Revenue barely moved, yet operating profit surged by more than 60%. The shift lies entirely in the payroll: average headcount fell by over forty, removing more than four million pounds from total staff costs and dropping the savings straight to the bottom line.
If you need me, I will be reviewing the corporate ROI on polo sponsorships from my basket.
Sources
- Coutts & Company
- Churchill Living (Developments) Plc
- Industrial Light & Magic (Uk) Ltd.
- Charles Wells Limited
- Oxford Pharmagenesis Holdings Limited